Phase
Condition
Mitral Valve Regurgitation
Treatment
Innovalve MR system
Clinical Study ID
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Clinically significant, symptomatic mitral regurgitation
High risk for open-heart surgery
Meets anatomical criteria
Exclusion
Exclusion Criteria:
Unsuitable anatomy
Patient is inoperable
EF<25%
Study Design
Study Description
Connect with a study center
Cedars-Sinai
Los Angeles, California 90048
United StatesActive - Recruiting
Piedmont Heart Institute
Atlanta, Georgia 30309
United StatesActive - Recruiting
University of Michigan Hospital and Health Systems
Ann Arbor, Michigan 48109
United StatesActive - Recruiting
Mayo Clinic
Rochester, Minnesota 555905
United StatesActive - Recruiting
Cornell
New York, New York 10021
United StatesActive - Recruiting
NYU Langone Health
New York, New York 10016
United StatesSite Not Available
NewYork-Presbyterian / Columbia University
New York, New York 10032
United StatesActive - Recruiting
Cleveland Clinic
Cleveland, Ohio 44195
United StatesActive - Recruiting
OhioHealth Research Institute
Columbus, Ohio 43214
United StatesActive - Recruiting
Oregon Health & Science Universtiy
Portland, Oregon 97239
United StatesActive - Recruiting
University of Pennsylvania
Philadelphia, Pennsylvania 19104
United StatesActive - Recruiting
Vanderbilt University Medical Center
Nashville, Tennessee 37203
United StatesActive - Recruiting
Swedish Medical Center
Seattle, Washington 98122
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.